Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2005522483-A |
titleOfInvention |
Binding agents and their use in targeting tumor cells |
abstract |
The present invention relates to methods and compositions for administering a binding agent to a patient such that the patient produces a response to an autologous tumor. The binding agent targets apoptotic tumor cells and promotes the uptake of these apoptotic tumor cells by dendritic cells or other antigen-presenting cells without expressing tumor-associated antigens in the blood (or in the blood Processing and presentation by the immune system (without the need for tumor antigens). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011007853-A1 |
priorityDate |
2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |